D.Western Therapeutics Institute Inc 4576.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 04/19/21 JST
304.00UNCH (UNCH)
52 week range
268.00 - 528.00

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close304.00
  • 52 Week High528.00
  • 52 Week High Date06/10/20
  • 52 Week Low268.00
  • 52 Week Low Date12/28/20

Key Stats

  • Market Cap79.3M
  • Shares Out29.25M
  • 10 Day Average Volume64,300
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change5.19

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close304.00
  • 52 Week High528.00
  • 52 Week High Date06/10/20
  • 52 Week Low268.00
  • 52 Week Low Date12/28/20
  • Market Cap79.3M
  • Shares Out29.25M
  • 10 Day Average Volume64,300
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change5.19

RATIOS/PROFITABILITY

  • EPS (TTM)-18.10
  • P/E (TTM)-16.80
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From D.Western Therapeutics Institute Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
D.Western Therapeutics Institute, Inc. is a Japan-based company engaged in the research and development of new pharmaceuticals. The Company generates revenue from licensing of its developed drugs to other companies. As of December 31, 2012, the Company’s drug pipeline included anti-thrombotic medicine K-134, therapeutic agent K-115 for glaucoma, and anticancer drug HMN-214. Its newly-developed products include new anti-thrombotic medicine and signal-transduction inhibitors...
Hiroyoshi Hidaka
Chairman
Yuichi Hidaka
President
Address
1-18-11, Nishiki
Nagoya-shi, ACH
460-0003
Japan